SCHEMBL26645352

SCHEMBL26645352

Cc1c[nH]c2nccc(-c3c(-c4cccc(Cl)c4)nn4c3CN(C(=O)/C=C/CN(C)C)CC4)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 4/20 0.41
▸ EGFR P00533 3/20 0.41
▸ MAPK8 P45983 1/20 0.40
▸ MAPK9 P45984 1/20 0.40
▸ ITK Q08881 2/20 0.37
▸ JAK3 P52333 4/20 0.37
▸ JAK2 O60674 3/20 0.36
▸ CCNK O75909 1/20 0.35
▸ CDK12 Q9NYV4 1/20 0.35
▸ LRRK2 Q5S007 2/20 0.35
▸ STK4 Q13043 1/20 0.35
▸ STK3 Q13188 1/20 0.35
▸ CLK2 P49760 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ LIMK2 P53671 2/20 0.35
▸ PLCG1 P19174 1/20 0.35
▸ LIMK1 P53667 1/20 0.35
▸ JAK1 P23458 2/20 0.35
▸ TYK2 P29597 2/20 0.35
▸ FLT3 P36888 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30622371 1.00 BTK (0.41) BTKEGFRMAPK8MAPK9ITK
SCHEMBL26644870 0.93 LIMK1 (0.37) BTKEGFRMAPK8MAPK9ITK
SCHEMBL30622420 0.93 LIMK1 (0.37) BTKEGFRMAPK8MAPK9ITK
SCHEMBL26645202 0.90 EGFR (0.45) BTKEGFRITKJAK3CLK2
SCHEMBL30622939 0.90 EGFR (0.45) BTKEGFRITKJAK3CLK2
SCHEMBL30622396 0.89 EGFR (0.36) BTKEGFRMAPK9JAK3JAK2
SCHEMBL30622307 0.88 JAK3 (0.44) EGFRJAK3JAK2LRRK2STK4
SCHEMBL26644961 0.88 JAK3 (0.44) EGFRJAK3JAK2LRRK2STK4
SCHEMBL30622354 0.86 BTK (0.38) BTKEGFRITKJAK3JAK2
SCHEMBL30622315 0.85 JAK3 (0.33) BTKEGFRITKJAK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback